Covered recipient · General Payments record
MCKENZIE TIBBS
General Payments · PY2023–2024
$1,006.21
- Reported across 35 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $774.93 | 28 |
| Education | $89.95 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $465.39 | 16 |
| Lilly USA, LLC | $115.33 | 2 |
| SANOFI-AVENTIS U.S. LLC | $89.95 | 1 |
| Janssen Biotech, Inc. | $89.39 | 5 |
| Incyte Corporation | $25.09 | 1 |
| Galderma Laboratories, L.P. | $24.60 | 1 |
| E.R. Squibb & Sons, L.L.C. | $20.92 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.59 | 1 |
| Amgen Inc. | $13.62 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $32.96 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225083 | CMS |
| ABBVIE INC. | $27.96 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225085 | CMS |
| ABBVIE INC. | $26.14 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225087 | CMS |
| ABBVIE INC. | $30.20 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225089 | CMS |
| ABBVIE INC. | $31.31 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225091 | CMS |
| ABBVIE INC. | $33.60 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225093 | CMS |
| ABBVIE INC. | $21.72 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225095 | CMS |
| ABBVIE INC. | $25.15 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225097 | CMS |
| ABBVIE INC. | $25.53 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225099 | CMS |
| ABBVIE INC. | $26.03 | 06/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225101 | CMS |
| ABBVIE INC. | $31.65 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225103 | CMS |
| ABBVIE INC. | $31.93 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225105 | CMS |
| ABBVIE INC. | $18.70 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225107 | CMS |
| ABBVIE INC. | $33.83 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225109 | CMS |
| ABBVIE INC. | $34.85 | 11/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225111 | CMS |
| ABBVIE INC. | $33.83 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106225113 | CMS |
| Amgen Inc. | $13.62 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117398928 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.59 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118200825 | CMS |
| E.R. Squibb & Sons, L.L.C. | $20.92 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101691092 | CMS |
| Galderma Laboratories, L.P. | $24.60 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145332071 | CMS |
| Incyte Corporation | $25.09 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141188765 | CMS |
| Janssen Biotech, Inc. | $19.31 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078791989 | CMS |
| Janssen Biotech, Inc. | $19.34 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078791712 | CMS |
| Janssen Biotech, Inc. | $13.76 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078792355 | CMS |
| Janssen Biotech, Inc. | $14.55 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078792092 | CMS |
| Janssen Biotech, Inc. | $22.43 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078791935 | CMS |
| Lilly USA, LLC | $95.99 | 11/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135198074 | CMS |
| Lilly USA, LLC | $19.34 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135170966 | CMS |
| SANOFI-AVENTIS U.S. LLC | $89.95 | 11/06/2024 | Education | Undisputed | 01/23/2026 | 1139841257 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.